Literature DB >> 10593996

Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.

F Faravelli1, M Upadhyaya, M Osborn, S M Huson, R Hayward, R Winter.   

Abstract

Neurofibromatosis type 1 (NF1) is one of the commonest autosomal dominant disorders in man. It is characterised by café au lait spots, peripheral neurofibromas, Lisch nodules, axillary freckling, skeletal dysplasia, and optic glioma. Symptomatic brain tumours occur in 1.5-2.2% of patients with NF1. We report here a family where seven members developed brain tumours. Of these, three have a clinical history strongly suggestive of NF1, while two do not fulfil diagnostic criteria for the disorder. A splice site mutation in exon 29 of the NF1 gene was found in these two subjects. This lesion is thought to be disease causative since it creates a frameshift and a premature termination of the neurofibromin protein. Different hypotheses to explain the unusual recurrence of brain tumours in this family, such as the nature of the mutation or cosegregation of other predisposing genes, are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593996      PMCID: PMC1734278     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

1.  Familial glioma in two siblings.

Authors:  D Uzal; E Ozyar; A Tükül; M Genç; F Söylemezoğlu; I L Atahan; B Onol
Journal:  Radiat Med       Date:  1996 Jan-Feb

2.  Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.

Authors:  M Upadhyaya; M J Osborn; J Maynard; M R Kim; F Tamanoi; D N Cooper
Journal:  Hum Genet       Date:  1997-01       Impact factor: 4.132

3.  Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours.

Authors:  G Thiel; K Marczinek; R Neumann; R Witkowski; D A Marchuk; P Nurnberg
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

4.  Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.

Authors:  F X Arredondo-Vega; I Santisteban; S Kelly; C M Schlossman; D T Umetsu; M S Hershfield
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

Review 5.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

6.  Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations.

Authors:  B L Wu; M A Austin; G H Schneider; R G Boles; B R Korf
Journal:  Am J Med Genet       Date:  1995-12-04

7.  Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.

Authors:  M Upadhyaya; J Maynard; M Osborn; S M Huson; M Ponder; B A Ponder; P S Harper
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

8.  Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.

Authors:  R A Lewis; V M Riccardi
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

9.  Distribution of 13 truncating mutations in the neurofibromatosis 1 gene.

Authors:  R A Heim; L N Kam-Morgan; C G Binnie; D D Corns; M C Cayouette; R A Farber; A S Aylsworth; L M Silverman; M C Luce
Journal:  Hum Mol Genet       Date:  1995-06       Impact factor: 6.150

10.  Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.

Authors:  L M Kayes; W Burke; V M Riccardi; R Bennett; P Ehrlich; A Rubenstein; K Stephens
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

View more
  3 in total

1.  Fatal glioblastoma multiforme in a patient with neurofibromatosis type I: the dilemma of systematic medical follow-up.

Authors:  Felix Distelmaier; Raimund Fahsold; Guido Reifenberger; Martina Messing-Juenger; Jörg Schaper; Dominik T Schneider; Ulrich Göbel; Ertan Mayatepek; Thorsten Rosenbaum
Journal:  Childs Nerv Syst       Date:  2006-08-29       Impact factor: 1.475

2.  Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

Authors:  Marike L D Broekman; Roelof Risselada; Jooyeon Engelen-Lee; Wim G M Spliet; Bon H Verweij
Journal:  Case Rep Med       Date:  2009-12-16

3.  Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis.

Authors:  Emma Mm Burkitt Wright; Emma Sach; Saba Sharif; Oliver Quarrell; Thomas Carroll; Richard W Whitehouse; Meena Upadhyaya; Susan M Huson; D Gareth R Evans
Journal:  J Med Genet       Date:  2013-06-28       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.